Extensive studies on the p38α MAPK role in the pathogenesis of AD clearly associate its increased activation with both the formation of positive lesions such as Aβ plaques and hyperphosphorylated tau protein NFTs, as well as with negative lesions, such as impairment in neuronal and synaptic functions and OS-induced neuronal damage. Here, MAPT is linked to Alzheimer disease.